ZA200604874B - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- ZA200604874B ZA200604874B ZA200604874A ZA200604874A ZA200604874B ZA 200604874 B ZA200604874 B ZA 200604874B ZA 200604874 A ZA200604874 A ZA 200604874A ZA 200604874 A ZA200604874 A ZA 200604874A ZA 200604874 B ZA200604874 B ZA 200604874B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- disclosed
- useful pharmaceutical
- compositions
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53156103P | 2003-12-19 | 2003-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200604874B true ZA200604874B (en) | 2007-03-28 |
Family
ID=34710234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200604874A ZA200604874B (en) | 2003-12-19 | 2006-06-13 | Pharmaceutical compositions |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20060009504A1 (ko) |
| EP (1) | EP1701699B1 (ko) |
| JP (1) | JP2007514758A (ko) |
| KR (1) | KR20060111581A (ko) |
| CN (1) | CN100528162C (ko) |
| AT (1) | ATE516011T1 (ko) |
| AU (1) | AU2004303425C1 (ko) |
| BR (1) | BRPI0417205A (ko) |
| CA (1) | CA2550071A1 (ko) |
| MX (1) | MXPA06007102A (ko) |
| NO (1) | NO20063293L (ko) |
| NZ (1) | NZ547557A (ko) |
| PL (1) | PL380665A1 (ko) |
| WO (1) | WO2005060981A2 (ko) |
| ZA (1) | ZA200604874B (ko) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1615646B2 (en) | 2003-04-08 | 2022-07-27 | Progenics Pharmaceuticals, Inc. | Pharmaceutical formulations containing methylnaltrexone |
| US20090041839A1 (en) * | 2007-05-23 | 2009-02-12 | Beasley Martin W | Pharmaceutical compositions for the treatment of pain |
| SE531698C2 (sv) | 2007-07-12 | 2009-07-07 | Respiratorius Ab | Nya bronkdilaterande a,b-omättade amider |
| JP6143409B2 (ja) | 2010-03-11 | 2017-06-07 | ワイス・エルエルシー | メチルナルトレキソンの経口製剤および親油性塩 |
| WO2012127472A1 (en) * | 2011-03-22 | 2012-09-27 | Mapi Pharma Ltd. | Process and intermediates for the preparation of preladenant and related compounds |
| CN106365221B (zh) * | 2016-11-09 | 2019-04-19 | 烟台史密得机电设备制造有限公司 | 一种金刚烷单季铵盐阳离子型三元复合驱采出水除油剂 |
| JP2020518673A (ja) | 2017-05-05 | 2020-06-25 | フュージョン・ファーマシューティカルズ・インコーポレイテッド | 二官能性キレートの薬物動態増強及びその使用 |
| KR20200004861A (ko) | 2017-05-05 | 2020-01-14 | 퓨전 파마슈티칼즈 인크. | Igf-1r 모노클로날 항체 및 그의 용도 |
| US10093741B1 (en) | 2017-05-05 | 2018-10-09 | Fusion Pharmaceuticals Inc. | IGF-1R monoclonal antibodies and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4656028A (en) * | 1986-06-24 | 1987-04-07 | Norcliff Thayer Inc. | Encapsulated antacid |
| US5935584A (en) * | 1994-01-13 | 1999-08-10 | Elizabeth Arden Company | Vitamin C delivery system |
| ES2287971T3 (es) * | 1997-08-11 | 2007-12-16 | Pfizer Products Inc. | Dispersiones farmaceuticas solidas con biodisponibilidad incrementada. |
| US6326390B1 (en) * | 1998-08-25 | 2001-12-04 | King Pharmaceuticals Reseach And Development, Inc. | Use of adenosine A3 receptor antagonists to inhibit tumor growth |
| US6921825B2 (en) * | 1998-09-16 | 2005-07-26 | King Pharmaceuticuals Research & Development, Inc. | Adenosine A3 receptor modulators |
| US6448253B1 (en) * | 1998-09-16 | 2002-09-10 | King Pharmaceuticals Research And Development, Inc. | Adenosine A3 receptor modulators |
| US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| MXPA01011981A (es) * | 1999-05-24 | 2003-09-04 | Sonus Pharma Inc | Vehiculo de emulsion para farmacos poco solubles. |
| JP4100865B2 (ja) * | 1999-12-13 | 2008-06-11 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 三環式縮合異項環化合物、その製造法およびその医薬 |
| MY132006A (en) | 2000-05-26 | 2007-09-28 | Schering Corp | ADENOSINE A2a RECEPTOR ANTAGONISTS |
| MXPA04003474A (es) * | 2001-10-15 | 2004-07-30 | Schering Corp | Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pirimidinas como antagonistas del receptor de adenosina a2a. |
| JP4284182B2 (ja) * | 2001-11-30 | 2009-06-24 | シェーリング コーポレイション | アデノシンＡ２ａレセプターアンタゴニスト |
| WO2003101455A2 (en) * | 2002-05-30 | 2003-12-11 | King Pharmaceuticals Research & Development, Inc. | Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| US6982253B2 (en) * | 2002-06-05 | 2006-01-03 | Supergen, Inc. | Liquid formulation of decitabine and use of the same |
-
2004
- 2004-12-17 BR BRPI0417205-1A patent/BRPI0417205A/pt not_active IP Right Cessation
- 2004-12-17 CN CNB2004800375628A patent/CN100528162C/zh not_active Expired - Fee Related
- 2004-12-17 JP JP2006545514A patent/JP2007514758A/ja active Pending
- 2004-12-17 AU AU2004303425A patent/AU2004303425C1/en not_active Ceased
- 2004-12-17 MX MXPA06007102A patent/MXPA06007102A/es active IP Right Grant
- 2004-12-17 PL PL380665A patent/PL380665A1/pl not_active Application Discontinuation
- 2004-12-17 CA CA002550071A patent/CA2550071A1/en not_active Abandoned
- 2004-12-17 NZ NZ547557A patent/NZ547557A/en not_active IP Right Cessation
- 2004-12-17 EP EP04814759A patent/EP1701699B1/en active Active
- 2004-12-17 WO PCT/US2004/042616 patent/WO2005060981A2/en active Application Filing
- 2004-12-17 AT AT04814759T patent/ATE516011T1/de not_active IP Right Cessation
- 2004-12-17 KR KR1020067011952A patent/KR20060111581A/ko not_active Application Discontinuation
- 2004-12-17 US US11/015,946 patent/US20060009504A1/en not_active Abandoned
-
2006
- 2006-06-13 ZA ZA200604874A patent/ZA200604874B/xx unknown
- 2006-07-14 NO NO20063293A patent/NO20063293L/no not_active Application Discontinuation
-
2008
- 2008-08-05 US US12/186,002 patent/US20080293734A1/en not_active Abandoned
-
2011
- 2011-04-04 US US13/079,378 patent/US20110207740A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE516011T1 (de) | 2011-07-15 |
| BRPI0417205A (pt) | 2007-02-06 |
| AU2004303425C1 (en) | 2010-02-18 |
| CN100528162C (zh) | 2009-08-19 |
| PL380665A1 (pl) | 2007-03-05 |
| CN1893921A (zh) | 2007-01-10 |
| AU2004303425A1 (en) | 2005-07-07 |
| US20080293734A1 (en) | 2008-11-27 |
| WO2005060981A2 (en) | 2005-07-07 |
| WO2005060981A3 (en) | 2005-12-29 |
| NO20063293L (no) | 2006-07-14 |
| MXPA06007102A (es) | 2006-08-23 |
| US20110207740A1 (en) | 2011-08-25 |
| EP1701699A2 (en) | 2006-09-20 |
| JP2007514758A (ja) | 2007-06-07 |
| EP1701699B1 (en) | 2011-07-13 |
| AU2004303425B2 (en) | 2009-03-26 |
| NZ547557A (en) | 2010-07-30 |
| US20060009504A1 (en) | 2006-01-12 |
| CA2550071A1 (en) | 2005-07-07 |
| KR20060111581A (ko) | 2006-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2389530B (en) | Pharmaceutical compositions | |
| LUC00065I2 (ko) | ||
| GB0320382D0 (en) | Pharmaceutical compositions | |
| GB0327723D0 (en) | Pharmaceutical compositions | |
| RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
| SG145694A1 (en) | Novel compounds | |
| UA90875C2 (ru) | Лекарственные формы пролонгированного действия, которые содержат ранолазин | |
| GB0301554D0 (en) | Immunostimulatory compositions | |
| MX2007007613A (es) | Formulaciones farmaceuticas. | |
| ZA200604874B (en) | Pharmaceutical compositions | |
| ZA200605080B (en) | Pharmaceutical compositions | |
| GB2391473B (en) | Pharmaceutical compositions | |
| GB0300531D0 (en) | Pharmaceutical compositions | |
| EP1648411A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| GB0213481D0 (en) | Pharmaceutical compositions | |
| EP1655029A4 (en) | MEDICINAL COMPOSITIONS | |
| HU0304095D0 (en) | Novel, effective pharmaceutical compositions | |
| EP1480649A4 (en) | STABLE PHARMACEUTICAL COMPOSITIONS | |
| GB0324574D0 (en) | Novel compositions | |
| GB0305579D0 (en) | Pharmaceutical compositions | |
| PL370907A1 (en) | Pharmaceutical compositions | |
| GB0310783D0 (en) | Pharmaceutical compositions | |
| GB0311752D0 (en) | Pharmaceutical compositions | |
| GB0302333D0 (en) | Pharmaceutical compositions | |
| GB0308633D0 (en) | Pharmaceutical compositions |